{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:09:22Z","timestamp":1775308162539,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,8]]},"DOI":"10.7759\/cureus.27767","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T10:58:45Z","timestamp":1659956325000},"source":"Crossref","is-referenced-by-count":4,"title":["Psoriasis a Cause of Cardiovascular Diseases: A Review Article"],"prefix":"10.7759","author":[{"given":"Aditi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Madke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12355","article-title":"Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis","volume":"169","author":"Dowlatshahi EA","year":"2013","unstructured":"Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013, 169:266-82. 10.1111\/bjd.12355","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000121333","article-title":"Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002","volume":"217","author":"Kimball AB","year":"2008","unstructured":"Kimball AB, Robinson D Jr, Wu Y, et al.. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology. 2008, 217:27-37. 10.1159\/000121333","journal-title":"Dermatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00999-9","article-title":"Biomarkers of subclinical atherosclerosis in patients with psoriasis","volume":"11","author":"Kaiser H","year":"2021","unstructured":"Kaiser H, Wang X, Kvist-Hansen A, et al.. Biomarkers of subclinical atherosclerosis in patients with psoriasis. Sci Rep. 2021, 11:21438. 10.1038\/s41598-021-00999-9","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001249","article-title":"Association between the systemic treatment of psoriasis and cardiovascular risk","volume":"134","author":"Shi LQ","year":"2021","unstructured":"Shi LQ, Lian N, Sun JT, Liu LH, Chen M. Association between the systemic treatment of psoriasis and cardiovascular risk. Chin Med J (Engl). 2021, 134:518-20. 10.1097\/CM9.0000000000001249","journal-title":"Chin Med J (Engl)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.11075","article-title":"Cardiovascular comorbidities in psoriasis (Review)","volume":"23","author":"Branisteanu DE","year":"2022","unstructured":"Branisteanu DE, Nicolescu AC, Branisteanu DC, et al.. Cardiovascular comorbidities in psoriasis (Review). Exp Ther Med. 2022, 23:152. 10.3892\/etm.2021.11075","journal-title":"Exp Ther Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","volume":"27 Suppl 3","author":"Horreau C","year":"2013","unstructured":"Horreau C, Pouplard C, Brenaut E, et al.. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013, 27 Suppl 3:12-29. 10.1111\/jdv.12163","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/187437220181201005","article-title":"Higher risk of future cardiovascular events among patients with psoriatic arthritis compared to psoriatic patients between the ages of 30-50. The","volume":"2","author":"Krajewska-W\u0142odarczyk M","year":"2018","unstructured":"Krajewska-W\u0142odarczyk M, Owczarczyk-Saczonek A, Placek W.. Higher risk of future cardiovascular events among patients with psoriatic arthritis compared to psoriatic patients between the ages of 30-50. The. Open Dermatology Journal. 2018, 2:30-50. 10.2174\/187437220181201005","journal-title":"Open Dermatology Journal"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0428-y","article-title":"Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis","volume":"16","author":"Semb AG","year":"2020","unstructured":"Semb AG, Ikdahl E, Wibetoe G, Crowson C, Rollefstad S. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat Rev Rheumatol. 2020, 16:361-79. 10.1038\/s41584-020-0428-y","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1490270\/v2","article-title":"Prediction of cardiovascular disease risk in patients with psoriasis in northern China","volume":"3","author":"Fu Q","year":"2022","unstructured":"Fu Q, qiang Su D, Miao Y, et al.. Prediction of cardiovascular disease risk in patients with psoriasis in northern China. PubMed. 2022, 3:34-45. 10.21203\/rs.3.rs-1490270\/v2","journal-title":"PubMed"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5455\/IJMRCR.psoriasis-172-1608692664","article-title":"Clinical profile of patients with psoriasis and associated cardiovascular comorbidity: a five-year retrospective hospital-based study in Makassar, Indonesia","volume":"23","author":"Djawad K","year":"2021","unstructured":"Djawad K. Clinical profile of patients with psoriasis and associated cardiovascular comorbidity: a five-year retrospective hospital-based study in Makassar, Indonesia. Int Jr Med Rev Cas Rep. 2021, 23:5. 10.5455\/IJMRCR.psoriasis-172-1608692664","journal-title":"Int Jr Med Rev Cas Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701064","article-title":"Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome","volume":"128","author":"Haider AS","year":"2008","unstructured":"Haider AS, Cohen J, Fei J, et al.. Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. J Invest Dermatol. 2008, 128:655-66. 10.1038\/sj.jid.5701064","journal-title":"J Invest Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes JE","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017, 140:645-53. 10.1016\/j.jaci.2017.07.004","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090822","article-title":"Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis","volume":"37","author":"Tobin AM","year":"2010","unstructured":"Tobin AM, Veale DJ, Fitzgerald O, Rogers S, Collins P, O'Shea D, Kirby B. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. J Rheumatol. 2010, 37:1386-94. 10.3899\/jrheum.090822","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0003319717702303","article-title":"Psoriasis and cardiovascular disease: Two sides of the same coin?","volume":"69","author":"Doumas M","year":"2018","unstructured":"Doumas M, Katsiki N, Papademetriou V. Psoriasis and cardiovascular disease: Two sides of the same coin?. Angiology. 2018, 69:5-9. 10.1177\/0003319717702303","journal-title":"Angiology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.207","article-title":"Psoriasis and cardiovascular disease: where is the risk?","volume":"133","author":"Maybury CM","year":"2013","unstructured":"Maybury CM, Barker JN, Smith CH. Psoriasis and cardiovascular disease: where is the risk?. J Invest Dermatol. 2013, 133:2308-11. 10.1038\/jid.2013.207","journal-title":"J Invest Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000603","article-title":"Psoriasis and cardiomyopathy: A review of the literature","volume":"110","author":"Hashim T","year":"2017","unstructured":"Hashim T, Ahmad A, Chaudry A, Khouzam R. Psoriasis and cardiomyopathy: A review of the literature. South Med J. 2017, 110:97-100. 10.14423\/SMJ.0000000000000603","journal-title":"South Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.03.024","article-title":"Impact of biological agents on imaging and biomarkers of cardiovascular disease in patients with psoriasis: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"141","author":"Gonz\u00e1lez-Cantero A","year":"2021","unstructured":"Gonz\u00e1lez-Cantero A, Ortega-Quijano D, \u00c1lvarez-D\u00edaz N, et al.. Impact of biological agents on imaging and biomarkers of cardiovascular disease in patients with psoriasis: A systematic review and meta-analysis of randomized placebo-controlled trials. J Invest Dermatol. 2021, 141:2402-11. 10.1016\/j.jid.2021.03.024","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.8209","article-title":"Cardiovascular and metabolic diseases comorbid with psoriasis: Beyond the skin","volume":"56","author":"Furue M","year":"2017","unstructured":"Furue M, Tsuji G, Chiba T, Kadono T. Cardiovascular and metabolic diseases comorbid with psoriasis: Beyond the skin. Intern Med. 2017, 56:1613-9. 10.2169\/internalmedicine.56.8209","journal-title":"Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2195","article-title":"Psoriasis and cardiovascular diseases: A literature review to determine the causal relationship","volume":"10","author":"Jindal S","year":"2018","unstructured":"Jindal S, Jindal N. Psoriasis and cardiovascular diseases: A literature review to determine the causal relationship. Cureus. 2018, 10:e2195. 10.7759\/cureus.2195","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.040","article-title":"Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis","volume":"79","author":"Lockshin B","year":"2018","unstructured":"Lockshin B, Balagula Y, Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 2018, 79:345-52. 10.1016\/j.jaad.2018.02.040","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2020.15.R2","article-title":"The association between psoriasis and cardiovascular diseases","volume":"16","author":"Zwain A","year":"2021","unstructured":"Zwain A, Aldiwani M, Taqi H. The association between psoriasis and cardiovascular diseases. Eur Cardiol. 2021, 16:e19. 10.15420\/ecr.2020.15.R2","journal-title":"Eur Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with\u00a0psoriasis: JACC review topic of the week","volume":"77","author":"Garshick MS","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular risk in patients with\u00a0psoriasis: JACC review topic of the week. J Am Coll Cardiol. 2021, 77:1670-80. 10.1016\/j.jacc.2021.02.009","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01346-6","article-title":"Psoriasis and cardiovascular risk: A comprehensive review","volume":"37","author":"Masson W","year":"2020","unstructured":"Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: A comprehensive review. Adv Ther. 2020, 37:2017-33. 10.1007\/s12325-020-01346-6","journal-title":"Adv Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli YB","year":"2009","unstructured":"Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009, 160:1048-56. 10.1111\/j.1365-2133.2008.09020.x","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007394","article-title":"Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: A randomized placebo-controlled trial","volume":"11","author":"Mehta NN","year":"2018","unstructured":"Mehta NN, Shin DB, Joshi AA, et al.. Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: A randomized placebo-controlled trial. Circ Cardiovasc Imaging. 2018, 11:e007394. 10.1161\/CIRCIMAGING.117.007394","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-014-2277-y","article-title":"Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?","volume":"400","author":"Erfan G","year":"2015","unstructured":"Erfan G, Guzel S, Alpsoy S, et al.. Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?. Mol Cell Biochem. 2015, 400:207-12. 10.1007\/s11010-014-2277-y","journal-title":"Mol Cell Biochem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.136499","article-title":"Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis","volume":"70","author":"Jamnitski A","year":"2011","unstructured":"Jamnitski A, Visman IM, Peters MJ, Boers M, Dijkmans BA, Nurmohamed MT. Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis. Ann Rheum Dis. 2011, 70:875-6. 10.1136\/ard.2010.136499","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa025","article-title":"Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis-which target should we choose?","volume":"59","author":"Cheng IT","year":"2020","unstructured":"Cheng IT, Li EK, Wong PC, et al.. Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis-which target should we choose?. Rheumatology (Oxford). 2020, 59:2881-92. 10.1093\/rheumatology\/keaa025","journal-title":"Rheumatology (Oxford)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05739-y","article-title":"Psoriatic arthritis and physical activity: a systematic review","volume":"40","author":"Kessler J","year":"2021","unstructured":"Kessler J, Chouk M, Ruban T, Prati C, Wendling D, Verhoeven F. Psoriatic arthritis and physical activity: a systematic review. Clin Rheumatol. 2021, 40:4379-89. 10.1007\/s10067-021-05739-y","journal-title":"Clin Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa683","article-title":"The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids","volume":"60","author":"Persson R","year":"2021","unstructured":"Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids. Rheumatology (Oxford). 2021, 60:1926-31. 10.1093\/rheumatology\/keaa683","journal-title":"Rheumatology (Oxford)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa448","article-title":"Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database","volume":"60","author":"Pina Vegas L","year":"2021","unstructured":"Pina Vegas L, Sbidian E, Penso L, Claudepierre P. Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database. Rheumatology (Oxford). 2021, 60:1243-51. 10.1093\/rheumatology\/keaa448","journal-title":"Rheumatology (Oxford)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.08.013","article-title":"Cardiovascular risk and psoriasis: beyond the traditional risk factors","volume":"127","author":"Coumbe AG","year":"2014","unstructured":"Coumbe AG, Pritzker MR, Duprez DA. Cardiovascular risk and psoriasis: beyond the traditional risk factors. Am J Med. 2014, 127:12-8. 10.1016\/j.amjmed.2013.08.013","journal-title":"Am J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-01972-0","article-title":"Psoriasis as risk factor for non-ischemic dilated cardiomyopathy: a population-based cross-sectional study","volume":"21","author":"Alshami A","year":"2021","unstructured":"Alshami A, Alfraji N, Douedi S, Patel S, Hossain M, Alpert D, Calderon D. Psoriasis as risk factor for non-ischemic dilated cardiomyopathy: a population-based cross-sectional study. BMC Cardiovasc Disord. 2021, 21:161. 10.1186\/s12872-021-01972-0","journal-title":"BMC Cardiovasc Disord"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X19880742","article-title":"Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis","volume":"11","author":"Barbarroja N","year":"2019","unstructured":"Barbarroja N, Arias-de la Rosa I, L\u00f3pez-Medina C, et al.. Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Ther Adv Musculoskelet Dis. 2019, 11:1759720X19880742. 10.1177\/1759720X19880742","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106168-psoriasis-a-cause-of-cardiovascular-diseases-a-review-article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:52Z","timestamp":1707507412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106168-psoriasis-a-cause-of-cardiovascular-diseases-a-review-article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.27767","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,8]]}}}